Small molecule Drugs, Illustration

Small molecule Drugs, Illustration

C027/7528 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 16.3MB

Downloadable file size: 2.1MB

Price image Pricing

Please login to use the price calculator



Caption: Editorial medical illustration depicting the differences between biosimilars (or follow-on biologics), a biologic medical product, versus chemically constructed small molecule drugs. Biosimilars, a class of biologic medicine, are much bigger in size and more complex on the molecular level than small molecule drugs. On the right is the small molecule structure of aspirin (21 molecules), whereas the left side shows a monoclonal antibody made up of approximately 10,000-20,000 molecules. The various biosimilar drugs depicted include monoclonal antibodies, scFv, Fab, and scFab, whereas the small molecule drugs are identical. Also shown is a vial used for recombinant DNA procedures with plasmids as vectors and the desired fragments of DNA which are attached to the plasmids, forming recombinant plasmids. These are inserted into various living organisms. Among the living organisms shown is gram-negative bacteria (E. coli and Proteus mirabilis), gram-positive.

Release details: Model release not required. Property release not required.

Keywords: art, artwork, aspergillus niger var. awamori, aspirin 21 molecules, bacillus subtilis, biologic medical product, biologic medicine, biosimilar drugs, biosimilars, collage, conceptual, e. coli, editorial, editorial illustration, fab, fermentation tank, filamentous fungi, follow-on biologics, fragments of dna, gram-negative bacteria, gram-positive bacteria, graphic, illustration, leishmania tarentolae, living organisms, medical, medicine, molecules, monoclonal antibodies, monoclonal antibody, montage, pharmaceuticals, pharmacology, pichia pastors, plasmids, proteus mirabilis, protozoa, recombinant dna procedures, recombinant plasmids, scfab, scfv, small molecule drugs, small molecule drugs. biosimilars, small molecule structure, subsequent entry biologic, vectors, yeast

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.